Quantification of parasite burden of Trypanosoma cruzi and identification of Discrete Typing Units (DTUs) in blood samples of Latin American immigrants residing in Barcelona, Spain.
Adult
Aged
Aged, 80 and over
Animals
Bolivia
/ ethnology
Chagas Disease
/ ethnology
DNA, Protozoan
/ genetics
Emigrants and Immigrants
Female
Genetic Variation
Genotype
Humans
Male
Middle Aged
Molecular Typing
Parasite Load
Sequence Analysis, DNA
Spain
/ epidemiology
Trypanosoma cruzi
/ classification
Young Adult
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
07
02
2020
accepted:
20
04
2020
entrez:
5
6
2020
pubmed:
5
6
2020
medline:
11
8
2020
Statut:
epublish
Résumé
Trypanosoma cruzi has a high genetic and biological diversity and has been subdivided into seven genetic lineages, named TcI-TcVI and TcBat. DTUs TcI-TcII-TcV and TcVI are agents of ChD in different regions of Latin America. Due to population movements, the disease is an emergent global public health problem. Thus, the aim of this study was to quantify the parasitic load and identify the presence of T. cruzi DTUs in 101 Latin American immigrants with chronic ChD, residing in Barcelona, Spain. 5ml of peripheral blood were collected in guanidine/EDTA from each patient for DNA extraction, quantification of the parasitic load and genotyping. A great variation of the parasitic load of the patients was verified: from 0.001 to 22.2 T. cruzi DNA (fg) / Blood DNA (ng). In patients from Bolivia the parasitic load was 3.76±4.43 T. cruzi DNA (fg) / Blood DNA (ng) (mean ± SD), in patients of other countries was 0.95±1.38 T. cruzi DNA (fg) / Blood DNA (ng). No statistically significant difference was observed in the parasitic load between patients with the indeterminate and cardiac forms of ChD (p = 0,57). Parasite genotyping was performed by multilocus conventional PCR. In patients from Bolivia there was a nearly equal prevalence of DTUs TcV (27/77), TcII/TcV/TcVI (26/77), and TcII/TcVI (22/77). TcVI was detected in only 2 samples (2/77). A higher prevalence of TcII/TcVI (19/24) was verified in patients of other countries, with low prevalence of TcII/TcV/TcVI (4/24) and TcV (1/24). In this study, low/medium parasitic load was found in all patients evaluated. Our data corroborate previous conclusions indicating that patients from the Bolivia, living in Spain, are predominantly infected by TcV, and TcVI DTUs. On the other hand, in Non-Bolivians patients TcII/TcVI predominated. Surprisingly, in our cohort of 101 patients no infection by TcI DTU was observed.
Sections du résumé
BACKGROUND
Trypanosoma cruzi has a high genetic and biological diversity and has been subdivided into seven genetic lineages, named TcI-TcVI and TcBat. DTUs TcI-TcII-TcV and TcVI are agents of ChD in different regions of Latin America. Due to population movements, the disease is an emergent global public health problem. Thus, the aim of this study was to quantify the parasitic load and identify the presence of T. cruzi DTUs in 101 Latin American immigrants with chronic ChD, residing in Barcelona, Spain.
METHODOLOGY / PRINCIPAL FINDINGS
5ml of peripheral blood were collected in guanidine/EDTA from each patient for DNA extraction, quantification of the parasitic load and genotyping. A great variation of the parasitic load of the patients was verified: from 0.001 to 22.2 T. cruzi DNA (fg) / Blood DNA (ng). In patients from Bolivia the parasitic load was 3.76±4.43 T. cruzi DNA (fg) / Blood DNA (ng) (mean ± SD), in patients of other countries was 0.95±1.38 T. cruzi DNA (fg) / Blood DNA (ng). No statistically significant difference was observed in the parasitic load between patients with the indeterminate and cardiac forms of ChD (p = 0,57). Parasite genotyping was performed by multilocus conventional PCR. In patients from Bolivia there was a nearly equal prevalence of DTUs TcV (27/77), TcII/TcV/TcVI (26/77), and TcII/TcVI (22/77). TcVI was detected in only 2 samples (2/77). A higher prevalence of TcII/TcVI (19/24) was verified in patients of other countries, with low prevalence of TcII/TcV/TcVI (4/24) and TcV (1/24).
CONCLUSIONS/SIGNIFICANCE
In this study, low/medium parasitic load was found in all patients evaluated. Our data corroborate previous conclusions indicating that patients from the Bolivia, living in Spain, are predominantly infected by TcV, and TcVI DTUs. On the other hand, in Non-Bolivians patients TcII/TcVI predominated. Surprisingly, in our cohort of 101 patients no infection by TcI DTU was observed.
Identifiants
pubmed: 32497037
doi: 10.1371/journal.pntd.0008311
pii: PNTD-D-20-00200
pmc: PMC7271996
doi:
Substances chimiques
DNA, Protozoan
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0008311Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Mem Inst Oswaldo Cruz. 2011 Dec;106(8):948-56
pubmed: 22241116
Acta Trop. 2018 Aug;184:38-52
pubmed: 28941731
Epidemiol Serv Saude. 2016 Jun;25(spe):7-86
pubmed: 27869914
Mem Inst Oswaldo Cruz. 2009 Nov;104(7):1051-4
pubmed: 20027478
PLoS Negl Trop Dis. 2018 Nov 12;12(11):e0006939
pubmed: 30418976
Transfusion. 2015 Jun;55(6):1249-55
pubmed: 25683267
Parasitology. 2009 Oct;136(12):1509-28
pubmed: 19691868
Acta Trop. 2011 Jul;119(1):1-4
pubmed: 21510916
Proc Natl Acad Sci U S A. 1986 Jan;83(1):115-9
pubmed: 3510428
Parasit Vectors. 2015 Oct 31;8:568
pubmed: 26520576
Infect Genet Evol. 2012 Mar;12(2):240-53
pubmed: 22226704
Am J Trop Med Hyg. 1986 Sep;35(5):931-6
pubmed: 3094393
Parasitol Int. 2017 Apr;66(2):83-88
pubmed: 27940065
PLoS Negl Trop Dis. 2016 Sep 20;10(9):e0004997
pubmed: 27648938
Acta Trop. 2010 Jul-Aug;115(1-2):22-7
pubmed: 19646412
Nature. 2010 Jun 24;465(7301):S6-7
pubmed: 20571554
Lancet. 2018 Jan 6;391(10115):82-94
pubmed: 28673423
PLoS Negl Trop Dis. 2016 Aug 29;10(8):e0004792
pubmed: 27571035
Int J Parasitol. 2008 Jun;38(7):839-50
pubmed: 18154957
Clin Infect Dis. 2009 Jun 15;48(12):1736-40
pubmed: 19438393
Acta Trop. 2007 Sep;103(3):195-200
pubmed: 17662227
Euro Surveill. 2011 Sep 15;16(37):
pubmed: 21944556
Acta Trop. 2016 May;157:145-50
pubmed: 26851167
Lancet. 2013 Apr 6;381(9873):1235-45
pubmed: 23541058
PLoS Negl Trop Dis. 2015 Feb 13;9(2):e0003540
pubmed: 25680190
Clin Infect Dis. 2010 Sep 1;51(5):485-95
pubmed: 20645859
Acta Trop. 2013 Jan;125(1):23-31
pubmed: 22982466
Mem Inst Oswaldo Cruz. 2004 Feb;99(1):1-12
pubmed: 15057339
Mol Biochem Parasitol. 2003 Jun;129(1):53-9
pubmed: 12798506
Rev Inst Med Trop Sao Paulo. 1963 Sep-Oct;5:220-4
pubmed: 14110094
PLoS Negl Trop Dis. 2013;7(1):e2000
pubmed: 23350002
Acta Trop. 2015 Nov;151:156-65
pubmed: 26188332
Methods Mol Biol. 2019;1955:227-238
pubmed: 30868531
Nat Commun. 2018 Apr 17;9(1):1513
pubmed: 29666415
PLoS One. 2018 Nov 29;13(11):e0208133
pubmed: 30496249
PLoS Negl Trop Dis. 2010 Feb 02;4(2):e592
pubmed: 20126397